DUB Therapeutics is a preclinical biotechnology company developing anti-fibrotic self-delivering siRNAs across multiple therapeutic areas. We are proud to share that we have been recognized by the American Academy of Ophthalmology for our innovative approach using our novel anti-fibrotic self-delivering siRNA (sdRNA) technology in the treatment of ocular surface diseases and procedures. 
We look forward to sharing our plans for improving quality of life for millions of patients living with fibrotic diseases worldwide.

DUB Therapeutics

Org chart

Teams

Offices